绿色地中海饮食对肝内脂肪的影响:DIRECT PLUS随机对照试验
DIRECT-PLUS 18个月随机对照试验将294名腹型肥胖/血脂异常者分为健康饮食指南组、地中海饮食组和绿色地中海饮食组,均配合运动。绿色地中海饮食组在限制红肉/加工肉基础上增加绿茶和Mankai浮萍,肝内脂肪比例降幅近乎地中海饮食组两倍,非酒精性脂肪肝患病率降至31.5%。
要点
- 绿色地中海饮食组肝内脂肪比例相对下降38.9%,约为地中海饮食组(19.6%)两倍。
- 18个月后非酒精性脂肪肝患病率:健康指南组54.8%、地中海组47.9%、绿色地中海组31.5%。
- 肝内脂肪减少与Mankai和核桃摄入增加、红肉/加工肉减少及微生物组变化独立相关。
核心结论
- 绿色地中海饮食(增加Mankai、绿茶和核桃,限制红肉/加工肉)可使肝内脂肪降幅翻倍,并将非酒精性脂肪肝患病率降低约一半。
研究设计与样本
- DIRECT-PLUS 18个月随机对照试验,纳入294名腹型肥胖/血脂异常参与者,随机分入健康饮食指南组、地中海饮食组和绿色地中海饮食组,均配合运动。
- 两组等地中海饮食组每日摄入28克核桃(提供440毫克/天多酚),绿色地中海饮食组额外每日摄入3-4杯绿茶和100克Mankai浮萍冻块(提供1240毫克/天总多酚)。
- 肝内脂肪百分比变化通过质子磁共振波谱连续定量,18个月保留率89.8%,78%有合格随访磁共振波谱。
主要发现
- 非酒精性脂肪肝患病率降至健康饮食指南组54.8%、地中海饮食组47.9%、绿色地中海饮食组31.5%,组间p=0.012。
- 绿色地中海饮食组肝内脂肪比例相对下降38.9%,地中海饮食组下降19.6%(体重减轻校正后p=0.035),健康饮食指南组下降12.2%(p<0.001)。
- 18个月后两地中海饮食组总血浆多酚水平显著高于健康饮食指南组,绿色地中海饮食组中Naringenin和2-5-二羟基苯甲酸检出更高。
- 肝内脂肪百分比更大降幅独立关联于Mankai和核桃摄入增加、红肉/加工肉消费减少、血清叶酸和脂肪因子/脂质生物标志物改善及微生物组组成变化(均p<0.05)。
临床怎么用
- 对腹型肥胖/血脂异常合并非酒精性脂肪肝者,可考虑在限制红肉/加工肉基础上,采用富含绿色植物蛋白和多酚的绿色地中海饮食模式。
- 绿色地中海饮食可配合每日核桃、绿茶和Mankai浮萍摄入,以增强肝内脂肪降低效果。
局限性
- 参与者88%为男性,年龄51岁,体重指数31.3 kg/m2,中位肝内脂肪6.6%,平均10.2%,62%合并非酒精性脂肪肝,结果外推需谨慎。
- 18个月保留率89.8%,仅78%有合格随访磁共振波谱数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the effectiveness of green-Mediterranean (MED) diet, further restricted in red/processed meat, and enriched with green plants and polyphenols on non-alcoholic fatty liver disease (NAFLD), reflected by intrahepatic fat (IHF) loss. DESIGN: For the DIRECT-PLUS 18-month randomized clinical trial, we assigned 294 participants with abdominal obesity/dyslipidaemia into healthy dietary guidelines (HDG), MED and green-MED weight-loss diet groups, all accompanied by physical activity. Both isocaloric MED groups consumed 28 g/day walnuts (+440 mg/day polyphenols provided). The green-MED group further consumed green tea (3-4 cups/day) and Mankai (a Wolffia globosa aquatic plant strain; 100 g/day frozen cubes) green shake (+1240 mg/day total polyphenols provided). IHF% 18-month changes were quantified continuously by proton magnetic resonance spectroscopy (MRS). RESULTS: Participants (age=51 years; 88% men; body mass index=31.3 kg/m2; median IHF%=6.6%; mean=10.2%; 62% with NAFLD) had 89.8% 18-month retention-rate, and 78% had eligible follow-up MRS. Overall, NAFLD prevalence declined to: 54.8% (HDG), 47.9% (MED) and 31.5% (green-MED), p=0.012 between groups. Despite similar moderate weight-loss in both MED groups, green-MED group achieved almost double IHF% loss (-38.9% proportionally), as compared with MED (-19.6% proportionally; p=0.035 weight loss adjusted) and HDG (-12.2% proportionally; p<0.001). After 18 months, both MED groups had significantly higher total plasma polyphenol levels versus HDG, with higher detection of Naringenin and 2-5-dihydroxybenzoic-acid in green-MED. Greater IHF% loss was independently associated with increased Mankai and walnuts intake, decreased red/processed meat consumption, improved serum folate and adipokines/lipids biomarkers, changes in microbiome composition (beta-diversity) and specific bacteria (p<0.05 for all). CONCLUSION: The new suggested strategy of green-Mediterranean diet, amplified with green plant-based proteins/polyphenols as Mankai, green tea, and walnuts, and restricted in red/processed meat can double IHF loss than other healthy nutritional strategies and reduce NAFLD in half. TRIAL REGISTRATION NUMBER: NCT03020186.
引用
- Yaskolka Meir A, Rinott E, Tsaban G, et al. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut. 2021. PMID: 33461965. doi:10.1136/gutjnl-2020-323106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。